Bowen Zhu

机构：Sun Yat-sen University, Beijing Forestry University, Ministry of Education, The First Affiliated Hospital, Sun Yat-sen University, Southern Medical University Shenzhen Hospital · ORCID：0000-0003-0375-9664

发表论文 33 篇 · 总被引 1108 次 · h-index 11

代表论文

• Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH) (2022 · Journal of Clinical Oncology · 被引 459)
• TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma (2023 · Journal of Hepatology · 被引 230)
• Survival in Patients With Recurrent Intermediate-Stage Hepatocellular Carcinoma (2024 · JAMA Oncology · 被引 59)
• Anti-PD-L1 antibody enhances curative effect of cryoablation via antibody-dependent cell-mediated cytotoxicity mediating PD-L1highCD11b+ cells elimination in hepatocellular carcinoma (2022 · Acta Pharmaceutica Sinica B · 被引 24)
• Idarubicin‐Loaded DEB‐TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score‐matching analysis (2022 · Cancer Medicine · 被引 17)
• Altered Gut Microbiota Contributes to Acute-Respiratory-Distress-Syndrome-Related Depression through Microglial Neuroinflammation (2025 · Research · 被引 15)